These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 25926483)

  • 1. DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime?
    van de Pavert SH; Muhlert N; Sethi V; Wheeler-Kingshott CA; Ridgway GR; Geurts JJ; Ron M; Yousry TA; Thompson AJ; Miller DH; Chard DT; Ciccarelli O
    J Neurol Neurosurg Psychiatry; 2016 May; 87(5):461-7. PubMed ID: 25926483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Cortical and Deep Gray Matter Lesions in Multiple Sclerosis Using DIR and FLAIR at 3T.
    Park CC; Thongkham DW; Sadigh G; Saindane AM; Chu R; Bakshi R; Allen JW; Hu R
    J Neuroimaging; 2021 Mar; 31(2):408-414. PubMed ID: 33351983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of gray-matter multiple sclerosis lesions using double inversion recovery, diffusion, contrast-enhanced, and volumetric MRI.
    Parra Corral MA; Govindarajan ST; Stefancin P; Bangiyev L; Coyle PK; Duong TQ
    Mult Scler Relat Disord; 2019 Jun; 31():74-81. PubMed ID: 30951968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
    Galego O; Gouveia A; Batista S; Moura C; Machado E
    Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of regional grey matter atrophy in multiple sclerosis.
    Eshaghi A; Marinescu RV; Young AL; Firth NC; Prados F; Jorge Cardoso M; Tur C; De Angelis F; Cawley N; Brownlee WJ; De Stefano N; Laura Stromillo M; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Geurts JJG; Vrenken H; Wottschel V; Leurs CE; Uitdehaag B; Pirpamer L; Enzinger C; Ourselin S; Gandini Wheeler-Kingshott CA; Chard D; Thompson AJ; Barkhof F; Alexander DC; Ciccarelli O
    Brain; 2018 Jun; 141(6):1665-1677. PubMed ID: 29741648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
    Nocentini U; Bozzali M; Spanò B; Cercignani M; Serra L; Basile B; Mannu R; Caltagirone C; De Luca J
    Brain Imaging Behav; 2014 Sep; 8(3):378-86. PubMed ID: 22584774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gray Matter Atrophy in the Cortico-Striatal-Thalamic Network and Sensorimotor Network in Relapsing-Remitting and Primary Progressive Multiple Sclerosis.
    Cao Y; Diao W; Tian F; Zhang F; He L; Long X; Zhou F; Jia Z
    Neuropsychol Rev; 2021 Dec; 31(4):703-720. PubMed ID: 33582965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis.
    Eshaghi A; Bodini B; Ridgway GR; García-Lorenzo D; Tozer DJ; Sahraian MA; Thompson AJ; Ciccarelli O
    Neuroimage; 2014 Feb; 86():257-64. PubMed ID: 24099844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of deep grey matter volume on cognition in multiple sclerosis.
    Lorefice L; Carta E; Frau J; Contu F; Casaglia E; Coghe G; Barracciu MA; Cocco E; Fenu G
    Mult Scler Relat Disord; 2020 Oct; 45():102351. PubMed ID: 32731200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional patterns of grey matter atrophy and magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups: a voxel-based analysis study.
    Mallik S; Muhlert N; Samson RS; Sethi V; Wheeler-Kingshott CA; Miller DH; Chard DT
    Mult Scler; 2015 Apr; 21(4):423-32. PubMed ID: 25145689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.
    Steenwijk MD; Geurts JJ; Daams M; Tijms BM; Wink AM; Balk LJ; Tewarie PK; Uitdehaag BM; Barkhof F; Vrenken H; Pouwels PJ
    Brain; 2016 Jan; 139(Pt 1):115-26. PubMed ID: 26637488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis.
    Debernard L; Melzer TR; Alla S; Eagle J; Van Stockum S; Graham C; Osborne JR; Dalrymple-Alford JC; Miller DH; Mason DF
    Psychiatry Res; 2015 Dec; 234(3):352-61. PubMed ID: 26602610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gray matter atrophy is related to long-term disability in multiple sclerosis.
    Fisniku LK; Chard DT; Jackson JS; Anderson VM; Altmann DR; Miszkiel KA; Thompson AJ; Miller DH
    Ann Neurol; 2008 Sep; 64(3):247-54. PubMed ID: 18570297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Memory Deficits in Multiple Sclerosis: Voxel-based Morphometry and Double Inversion Recovery Analysis.
    Toko M; Kitamura J; Ueno H; Ohshita T; Nemoto K; Ochi K; Higaki T; Akiyama Y; Awai K; Maruyama H
    Intern Med; 2021; 60(1):39-46. PubMed ID: 33390470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voxel-Based quantitative MRI reveals spatial patterns of grey matter alteration in multiple sclerosis.
    Lommers E; Guillemin C; Reuter G; Fouarge E; Delrue G; Collette F; Degueldre C; Balteau E; Maquet P; Phillips C
    Hum Brain Mapp; 2021 Mar; 42(4):1003-1012. PubMed ID: 33155763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis.
    Brass SD; Benedict RH; Weinstock-Guttman B; Munschauer F; Bakshi R
    Mult Scler; 2006 Aug; 12(4):437-44. PubMed ID: 16900757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis.
    Ruggieri S; Petracca M; Miller A; Krieger S; Ghassemi R; Bencosme Y; Riley C; Howard J; Lublin F; Inglese M
    JAMA Neurol; 2015 Dec; 72(12):1466-74. PubMed ID: 26457955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal subcortical nuclei shapes in patients with type 2 diabetes mellitus.
    Chen J; Zhang J; Liu X; Wang X; Xu X; Li H; Cao B; Yang Y; Lu J; Chen Z
    Eur Radiol; 2017 Oct; 27(10):4247-4256. PubMed ID: 28374074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of cerebellar damage in explaining disability and cognition in multiple sclerosis phenotypes: a multiparametric MRI study.
    Bonacchi R; Meani A; Pagani E; Marchesi O; Filippi M; Rocca MA
    J Neurol; 2022 Jul; 269(7):3841-3857. PubMed ID: 35230471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
    Mühlau M; Buck D; Förschler A; Boucard CC; Arsic M; Schmidt P; Gaser C; Berthele A; Hoshi M; Jochim A; Kronsbein H; Zimmer C; Hemmer B; Ilg R
    Mult Scler; 2013 Oct; 19(11):1485-92. PubMed ID: 23462349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.